Skip to main content
SpringerLink
Log in

Viral disease challenge from new-style vaccine

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Cantab Pharmaceuticals has developed a rationally attenuated virus that produces the comprehensive immune response of a live virus vaccine without the risk of uncontrolled infection. Delegates to a joint MRC/IBC meeting, Successful Exploitation of Biomedical Research [ London, UK; March ] were given a detailed report of the project and its therapeutic prospects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Ian Mundell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mundell, I. Viral disease challenge from new-style vaccine. Inpharma Wkly. 934, 3 (1994). https://doi.org/10.2165/00128413-199409340-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199409340-00003

Keywords

Search

Navigation